TIVORSAN PHARMACEUTICALS, INC.

Profile

Company Names

TIVORSAN PHARMACEUTICALS, INC.

Addresses

2049 CENTURY PARK EAST, SUITE 320, LOS ANGELES, CA 90067

Phone Numbers

310-424-1999

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$13,840,825.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2018-07-17 
$900,000.00 
$1,000,000.00 
$100,000.00 
Debt 
5
2017-03-17 
$4,474,000.00 
$4,474,000.00 
$0.00 
Equity 
4
2016-01-29 
$2,938,000.00 
$2,938,000.00 
$0.00 
Debt 
3
2014-11-12 
$1,636,250.00 
$1,636,250.00 
$0.00 
Equity 
2
2013-02-12 
$2,767,751.00 
$2,767,751.00 
$0.00 
Equity 
1
2011-02-23 
$1,124,824.00 
$1,124,824.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOEL 
 
BRAUNSTEIN 
DIRECTOR
NEXGEN MEDICAL SYSTEMS INC   |  CORREX INC   |  TIVORSAN PHARMACEUTICALS, INC.
JAMES 
 
CONNOLLY 
DIRECTOR
PAXVAX INC   |  PAXVAX, INC.   |  VAXESS TECHNOLOGIES, INC.   |  TIVORSAN PHARMACEUTICALS, INC.   |  NATOMAS LABS, INC.
JUSTIN 
 
FALLON 
DIRECTOR
TIVORSAN PHARMACEUTICALS, INC.
MICHAEL 
 
MEYERS 
EXECUTIVE OFFICER
ASK MELISSA LLC   |  ARCODA GLOBAL HEALTHCARE FUND LP   |  TRADEVERSITY, INC.   |  TIVORSAN PHARMACEUTICALS, INC.   |  QUOIN PHARMACEUTICALS, INC.   |  REFLEX CAREERS, INC.   |  ANALYTICS SERVICES, LLC   |  KLARISANA HEALTH, INC.
JOHN 
 
NICHOLSON 
DIRECTOR
TOUCHSTONE GOLD LTD   |  NEKTAR THERAPEUTICS   |  TIVORSAN PHARMACEUTICALS, INC.
JAY 
 
VENKATESAN 
DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-23 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-01-29 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-12 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-17 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-12 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
T.R. WINSTON + COMPANY, LLC
10571